ArticleActa pharmaceutica Sinica. B2021

Preclinical efficacy against acute myeloid leukaemia of SH1573, a novel mutant IDH2 inhibitor approved for clinical trials in China.

Zhiqiang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.